271 related articles for article (PubMed ID: 32979927)
1. Energy intake and expenditure in patients with Alzheimer's disease and mild cognitive impairment: the NUDAD project.
Doorduijn AS; de van der Schueren MAE; van de Rest O; de Leeuw FA; Hendriksen HMA; Teunissen CE; Scheltens P; van der Flier WM; Visser M
Alzheimers Res Ther; 2020 Sep; 12(1):116. PubMed ID: 32979927
[TBL] [Abstract][Full Text] [Related]
2. A Suboptimal Diet is Associated with Poorer Cognition: The NUDAD Project.
Fieldhouse JLP; Doorduijn AS; de Leeuw FA; Verhaar BJH; Koene T; Wesselman LMP; Schueren MV; Visser M; Rest OV; Scheltens P; Kester MI; Flier WMV
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32155876
[TBL] [Abstract][Full Text] [Related]
3. Associations of AD Biomarkers and Cognitive Performance with Nutritional Status: The NUDAD Project.
Doorduijn AS; Visser M; van de Rest O; Kester MI; de Leeuw FA; Boesveldt S; Fieldhouse JLP; van den Heuvel EGHM; Teunissen CE; Scheltens P; van der Flier WM; de van der Schueren MAE
Nutrients; 2019 May; 11(5):. PubMed ID: 31126170
[TBL] [Abstract][Full Text] [Related]
4. Energy and Protein Intake of Alzheimer's Disease Patients Compared to Cognitively Normal Controls: Systematic Review.
Doorduijn AS; van de Rest O; van der Flier WM; Visser M; de van der Schueren MAE
J Am Med Dir Assoc; 2019 Jan; 20(1):14-21. PubMed ID: 30100233
[TBL] [Abstract][Full Text] [Related]
5. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
[TBL] [Abstract][Full Text] [Related]
6. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
[TBL] [Abstract][Full Text] [Related]
7. Olfactory and gustatory functioning and food preferences of patients with Alzheimer's disease and mild cognitive impairment compared to controls: the NUDAD project.
Doorduijn AS; de van der Schueren MAE; van de Rest O; de Leeuw FA; Fieldhouse JLP; Kester MI; Teunissen CE; Scheltens P; van der Flier WM; Visser M; Boesveldt S
J Neurol; 2020 Jan; 267(1):144-152. PubMed ID: 31595376
[TBL] [Abstract][Full Text] [Related]
8. Discrimination ability of the Short Test of Mental Status (STMS) compared to the Mini Mental State Examination (MMSE) in the spectrum of normal cognition, mild cognitive impairment, and probable Alzheimer's disease dementia: The Turkish standardization study.
Çebi M; Babacan G; Öktem Tanör Ö; Gürvit H
J Clin Exp Neuropsychol; 2020 Jul; 42(5):450-458. PubMed ID: 32406297
[TBL] [Abstract][Full Text] [Related]
9. The association between macronutrient intake and cognition in individuals aged under 65 in China: a cross-sectional study.
Ding B; Xiao R; Ma W; Zhao L; Bi Y; Zhang Y
BMJ Open; 2018 Jan; 8(1):e018573. PubMed ID: 29317416
[TBL] [Abstract][Full Text] [Related]
10. Nutritional Status Is Associated With Clinical Progression in Alzheimer's Disease: The NUDAD Project.
Doorduijn AS; de van der Schueren MAE; van de Rest O; de Leeuw FA; Hendriksen HMA; Teunissen CE; Scheltens P; van der Flier WM; Visser M
J Am Med Dir Assoc; 2023 May; 24(5):638-644.e1. PubMed ID: 33239240
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
Futschek IE; Schernhammer E; Haslacher H; Stögmann E; Lehrner J
Exp Gerontol; 2023 Feb; 172():112045. PubMed ID: 36509298
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
[TBL] [Abstract][Full Text] [Related]
14. Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer's disease.
Baldeiras I; Santana I; Leitão MJ; Vieira D; Duro D; Mroczko B; Kornhuber J; Lewczuk P
Alzheimers Res Ther; 2019 Jan; 11(1):2. PubMed ID: 30611311
[TBL] [Abstract][Full Text] [Related]
15. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
[TBL] [Abstract][Full Text] [Related]
16. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
[TBL] [Abstract][Full Text] [Related]
17. Influence of plasma matrix metalloproteinase levels on longitudinal changes in Alzheimer's disease (AD) biomarkers and cognitive function in patients with mild cognitive impairment due to AD registered in the Alzheimer's Disease Neuroimaging Initiative database.
Abe K; Chiba Y; Hattori S; Yoshimi A; Asami T; Katsuse O; Suda A; Hishimoto A;
J Neurol Sci; 2020 Sep; 416():116989. PubMed ID: 32603972
[TBL] [Abstract][Full Text] [Related]
18. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
